A board-certified radiation oncologist with a focus on breast cancer, Pablo Lavagnini, M.D. is the director of radiation oncology at Cancer Treatment Centers of America (CTCA) in Philadelphia. Dr. Lavagnini earned a medical degree from the University of Uruguay Medical School, followed by post-graduate medical studies in anesthesiology. He completed a residency in radiation oncology at New York Medical College, St. Vincent’s Hospital, as well as a residency in radiation oncology and a fellowship in radiobiology and hyperthermia at Stanford University in Palo Alto, California.
After 23 years of practicing radiation oncology, Dr. Lavagnini introduced Intraoperative Radiation Therapy (IORT) with the Novac7 in the U.S. in 2010. With IORT, radiation oncologists can deliver a single dose of radiation during surgery and, in many cases, eliminate the need for weeks of external radiation. IORT protects healthy tissue, reducing side effects, allowing for better cosmetic results and helping patients to return to their lives faster. IORT has been used to treat early stage breast cancer patients and a number of different disease types, including head and neck cancers, cervical cancer, and sarcomas. After losing his mother to breast cancer, Dr. Lavagnini made it his life’s work to serve the breast cancer community, a mission that came full circle when his sister was diagnosed with breast cancer and became the first IORT patient he treated in the United States, at CTCA, in 2010.
Dr. Lavagnini is a member of the board of the International Society of Intraoperative Radiation Therapy (ISIORT) and has published the largest amount of U.S. experience on IORT and breast cancer treatment to date. Being a part of the Breastcancer.org allows him to partner with other experts so, together, they can share their knowledge, skills, and experience with even more women.